Dongcheng Pharmaceutical's Shanxi Jinzhong Nuclear Medicine Production Center Obtains Radioactive Drug Production License

Corporate Action
โดย Jiemian·CN·Read original
Summary · why it matters

Andike, a subsidiary of Dongcheng Pharmaceutical, has officially obtained a radioactive drug production license for its nuclear medicine production center in Jinzhong City, Shanxi Province, and put it into operation. The center is located in the University Town Industrial Park of the Jinzhong Development Zone in the Shanxi Demonstration Zone. This approval marks the addition of a new nuclear medicine production center for Andike, meeting the requirements for production.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 1

安迪科Private▲ Positive
Regulationrelevance

Andike officially receives license and starts operations at new production center.

© 2026 MarketDXNews